NFKB1 and cancer: NF-κB and STAT3 are two main pro-inflammatory signaling pathways that undoubtedly play major roles in inflammation-driven cancers where their-co-activation has a synergistic effect on expression of oncogenic and pro-inflammatory transcription targets47,48 (Fig. 9).